Cancer Biopsy Market, By Product (Services, Instruments, and Kits & Consumables), By Type, By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4410
|
Published Date
October 2025
|
Pages
388
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cancer Biopsy Market size was valued at US$ 32,268.12 Million in 2024, expanding at a CAGR of 8.23% from 2025 to 2032.
A cancer biopsy is a crucial medical procedure used to diagnose cancer by extracting a small sample of tissue, fluid, or cells from a suspicious area within the body for laboratory analysis. This examination helps determine whether cancer is present, identifies the specific type of cancer, and assesses its stage, thereby enabling physicians to develop an effective and personalized treatment plan. Depending on the location and nature of the abnormality, biopsies can be conducted through various methods, including needle biopsy, surgical biopsy, or endoscopic biopsy.
Advancements in biopsy techniques and diagnostic technologies have significantly improved the accuracy and safety of cancer detection. Minimally invasive procedures, such as image-guided needle biopsies, allow for precise targeting of tumors while minimizing patient discomfort and recovery time. Additionally, innovations in molecular and genetic analysis of biopsy samples are providing deeper insights into cancer biology, enabling the development of targeted therapies and personalized medicine approaches. These improvements are critical in enhancing early diagnosis, improving treatment outcomes, and ultimately increasing patient survival rates. According to the World Health Organization, cancer is one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020.
Cancer Biopsy Market- Market Dynamics
Rising global cancer prevalence driving increased demand in the market
The global cancer biopsy market is being propelled by a significant increase in cancer prevalence worldwide. According to the World Health Organization (WHO), nearly 20 million new cancer cases were reported in 2022, underscoring the critical need for accurate and timely diagnostic solutions. Governments and healthcare agencies are prioritizing early detection initiatives, which directly drive the demand for biopsy procedures. However, the high cost of advanced diagnostic techniques, such as liquid biopsy and next-generation sequencing, continues to limit accessibility in many low- and middle-income countries.
On the opportunity front, the adoption of liquid biopsy is gaining momentum. The U.S. Food and Drug Administration (FDA) has approved over 40 companion diagnostics for targeted cancer therapies, facilitating broader clinical integration and personalized treatment approaches. Additionally, major government initiatives like the U.S. Cancer Moonshot program and the European Union’s Beating Cancer Plan are injecting substantial funding into cancer research and diagnostic innovation. These combined efforts create a favorable market environment where increasing cancer incidence and supportive policies outweigh cost-related barriers, driving sustained growth across the globe.
Furthermore, ongoing advancements in biopsy technology, including minimally invasive and liquid biopsy methods, are revolutionizing cancer diagnostics by enabling earlier and more precise detection. These innovations not only improve patient comfort and reduce procedural risks but also allow for real-time monitoring of treatment response and disease progression. As healthcare systems worldwide increasingly adopt precision medicine, the demand for sophisticated biopsy tools and techniques is expected to rise, creating new opportunities for market expansion and improved patient outcomes.
Cancer Biopsy Market- Segmentation Analysis:
The Global Cancer Biopsy Market is segmented on the basis of Product, Type, Application, End User, and Region.
The market is segmented into three main product categories: services, instruments, and kits & consumables. Among these, the services segment is anticipated to hold the largest market share during the forecast period. This growth is fueled by the increasing demand for advanced diagnostic testing and pathology services, as well as the widespread adoption of minimally invasive biopsy procedures across the globe. Governments and healthcare agencies are actively supporting this trend; for instance, the U.S. National Cancer Institute (NCI) funds programs aimed at improving diagnostic capabilities and expanding access to pathology services, which further drives the growth of the services segment.
In terms of application, the market is divided into twelve cancer types, including breast, cervical, colorectal, prostate, lung, blood, skin, kidney, ovarian, pancreatic, liver cancers, and others. The breast cancer segment is expected to dominate the market, owing to its high prevalence worldwide, the expansion of breast cancer screening programs, and the increasing adoption of advanced diagnostic technologies such as molecular testing and imaging. Governments are playing a crucial role in this growth by launching nationwide awareness and screening campaigns. For example, the European Union’s Breast Cancer Initiative aims to improve early detection and diagnosis across member states, contributing significantly to market expansion in this segment.
Cancer Biopsy Market- Geographical Insights
North America dominates the global cancer biopsy market, accounting for over 40% of the total share. This leadership is driven by high cancer incidence rates and robust healthcare policies. According to U.S. Cancer Statistics, 279,731 new female breast cancer cases were reported in 2022, with overall cancer incidence steadily increasing each year. Key factors accelerating market growth include Medicare coverage for next-generation sequencing and FDA approvals of liquid biopsy tests like Guardant360 CDx, which have significantly boosted adoption rates.
In Europe, initiatives such as the EU’s Beating Cancer Plan aim to offer cancer screening to 90% of eligible citizens by 2025. Meanwhile, NHS England has expanded liquid biopsy pilot programs to enhance early cancer detection. The Asia Pacific region represents the fastest-growing market, with India’s Indian Council of Medical Research (ICMR) projecting 1.53 million new cancer cases in 2024, and Japan reporting approximately 1.01 million new cases in 2022. These factors are substantially driving biopsy demand in the region. Together, strong policy support, clear reimbursement pathways, and rising cancer incidence rates maintain North America’s dominance, while Europe and Asia Pacific are rapidly closing the gap.
Cancer Biopsy Market- Competitive Landscape:
The rising demand for early and accurate cancer diagnosis is prompting companies to innovate and improve efficiency in biopsy solutions. Industry players are focusing on developing minimally invasive biopsy techniques, integrating advanced imaging guidance, and enhancing molecular testing capabilities to boost diagnostic precision. Strategic partnerships with research institutions and healthcare providers are being pursued to broaden clinical applications. Additionally, investments in automation, digital pathology, and AI-powered diagnostics aim to accelerate result turnaround times, improve accuracy, and secure competitive advantages.
Recent Developments:
- In April 2025, Labcorp launched molecular residual disease and liquid biopsy testing services, providing advanced genomic insights to support personalized cancer treatment, improve disease monitoring, and enable early relapse detection across various cancer types.
- In June 2025, M42 announced a strategic collaboration with AstraZeneca and SOPHiA GENETICS to introduce cutting-edge liquid biopsy testing in the UAE, enhancing cancer diagnosis, treatment decision-making, and biomarker analysis to drive precision oncology outcomes.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER BIOPSY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- QIAGEN
- ANGLE plc
- Illumina, Inc.
- BD (Becton, Dickinson and Company)
- Hologic, Inc.
- Myriad Genetics, Inc.
- Biocept, Inc.
- Danaher
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- GRAIL, Inc.
- Lucence Health Inc.
- Guardant Health Inc.
- Freenome Holdings, Inc.
- Exact Sciences Corporation
- Biodesix (Integrated Diagnostics)
- Epigenomics AG
- Oncimmune
- HelioHealth (Laboratory for Advanced Medicine)
- Chronix Biomedical, Inc.
- Genesystems, Inc. (Genesys Biolabs)
- Personal Genome Diagnostics Inc.
- Personalis Inc.
- Natera, Inc.
- Others
GLOBAL CANCER BIOPSY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Services
- Instruments
- Kits & Consumables
GLOBAL CANCER BIOPSY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Liquid Biopsies
- Core Needle Biopsy (CNB)
- Fine Needle Aspiration (FNA)
- Tissue Biopsies
- Surgical Biopsies
- Needle Biopsies
- Others
GLOBAL CANCER BIOPSY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Prostate Cancer
- Lung Cancer
- Blood Cancer
- Skin Cancer
- Kidney Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Liver Cancer
- Others
GLOBAL CANCER BIOPSY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Centers
- Cancer Research Centers
- Research & Academics
GLOBAL CANCER BIOPSY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cancer Biopsy Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cancer Biopsy Market Snippet by Product
2.1.2. Cancer Biopsy Market Snippet by Type
2.1.3. Cancer Biopsy Market Snippet by Application
2.1.4. Cancer Biopsy Market Snippet by End User
2.1.5. Cancer Biopsy Market Snippet by Country
2.1.6. Cancer Biopsy Market Snippet by Region
2.2. Competitive Insights
3. Cancer Biopsy Key Market Trends
3.1. Cancer Biopsy Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cancer Biopsy Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cancer Biopsy Market Opportunities
3.4. Cancer Biopsy Market Future Trends
4. Cancer Biopsy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cancer Biopsy Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cancer Biopsy Market Landscape
6.1. Cancer Biopsy Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cancer Biopsy Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Services
7.1.3. Instruments
7.1.4. Kits & Consumables
8. Cancer Biopsy Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
8.1.2. Liquid Biopsies
8.1.2.1. Core Needle Biopsy (CNB)
8.1.2.2. Fine Needle Aspiration (FNA)
8.1.3. Tissue Biopsies
8.1.3.1. Surgical Biopsies
8.1.3.2. Needle Biopsies
8.1.4. Others
9. Cancer Biopsy Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Breast Cancer
9.1.3. Cervical Cancer
9.1.4. Colorectal Cancer
9.1.5. Prostate Cancer
9.1.6. Lung Cancer
9.1.7. Blood Cancer
9.1.8. Skin Cancer
9.1.9. Kidney Cancer
9.1.10. Ovarian Cancer
9.1.11. Pancreatic Cancer
9.1.12. Liver Cancer
9.1.13. Others
10. Cancer Biopsy Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Diagnostic Centers
10.1.4. Cancer Research Centers
10.1.5. Research & Academics
11. Cancer Biopsy Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Cancer Biopsy Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Cancer Biopsy Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Cancer Biopsy Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Cancer Biopsy Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Cancer Biopsy Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Cancer Biopsy Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. QIAGEN
12.2.2. ANGLE plc
12.2.3. Illumina, Inc.
12.2.4. BD (Becton, Dickinson and Company)
12.2.5. Hologic, Inc.
12.2.6. Myriad Genetics, Inc.
12.2.7. Biocept, Inc.
12.2.8. Danaher
12.2.9. Thermo Fisher Scientific, Inc.
12.2.10. F. Hoffmann-La Roche Ltd.
12.2.11. GRAIL, Inc.
12.2.12. Lucence Health Inc.
12.2.13. Guardant Health Inc.
12.2.14. Freenome Holdings, Inc.
12.2.15. Exact Sciences Corporation
12.2.16. Biodesix (Integrated Diagnostics)
12.2.17. Epigenomics AG
12.2.18. Oncimmune
12.2.19. HelioHealth (Laboratory for Advanced Medicine)
12.2.20. Chronix Biomedical, Inc.
12.2.21. Genesystems, Inc. (Genesys Biolabs)
12.2.22. Personal Genome Diagnostics Inc.
12.2.23. Personalis Inc.
12.2.24. Natera, Inc.
12.2.25. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
